276 related articles for article (PubMed ID: 16432413)
1. Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix.
Pietrzak WS; Woodell-May J; McDonald N
J Craniofac Surg; 2006 Jan; 17(1):84-90. PubMed ID: 16432413
[TBL] [Abstract][Full Text] [Related]
2. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products.
Bae HW; Zhao L; Kanim LE; Wong P; Delamarter RB; Dawson EG
Spine (Phila Pa 1976); 2006 May; 31(12):1299-306; discussion 1307-8. PubMed ID: 16721289
[TBL] [Abstract][Full Text] [Related]
3. Content of bone morphogenetic protein-4 in human demineralized bone: relationship to donor age and ability to induce new bone formation.
Honsawek S; Dhitiseith D
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S260-5. PubMed ID: 16623039
[TBL] [Abstract][Full Text] [Related]
4. Quantification of various growth factors in different demineralized bone matrix preparations.
Wildemann B; Kadow-Romacker A; Haas NP; Schmidmaier G
J Biomed Mater Res A; 2007 May; 81(2):437-42. PubMed ID: 17117475
[TBL] [Abstract][Full Text] [Related]
5. Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model.
Honsawek S; Powers RM; Wolfinbarger L
Cell Tissue Bank; 2005; 6(1):13-23. PubMed ID: 15735897
[TBL] [Abstract][Full Text] [Related]
6. The in vitro elution of BMP-7 from demineralized bone matrix.
Pietrzak WS; Dow M; Gomez J; Soulvie M; Tsiagalis G
Cell Tissue Bank; 2012 Dec; 13(4):653-61. PubMed ID: 22200971
[TBL] [Abstract][Full Text] [Related]
7. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2.
Lin H; Zhao Y; Sun W; Chen B; Zhang J; Zhao W; Xiao Z; Dai J
Biomaterials; 2008 Mar; 29(9):1189-97. PubMed ID: 18083224
[TBL] [Abstract][Full Text] [Related]
8. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
Behnam K; Murray SS; Brochmann EJ
Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
[TBL] [Abstract][Full Text] [Related]
9. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2.
Chen B; Lin H; Wang J; Zhao Y; Wang B; Zhao W; Sun W; Dai J
Biomaterials; 2007 Feb; 28(6):1027-35. PubMed ID: 17095085
[TBL] [Abstract][Full Text] [Related]
10. Variability across ten production lots of a single demineralized bone matrix product.
Bae H; Zhao L; Zhu D; Kanim LE; Wang JC; Delamarter RB
J Bone Joint Surg Am; 2010 Feb; 92(2):427-35. PubMed ID: 20124070
[TBL] [Abstract][Full Text] [Related]
11. Demineralized bone matrix graft: a scientific and clinical case study assessment.
Pietrzak WS; Perns SV; Keyes J; Woodell-May J; McDonald NM
J Foot Ankle Surg; 2005; 44(5):345-53. PubMed ID: 16210154
[TBL] [Abstract][Full Text] [Related]
12. Effect(s) of the demineralization process on the osteoinductivity of demineralized bone matrix.
Zhang M; Powers RM; Wolfinbarger L
J Periodontol; 1997 Nov; 68(11):1085-92. PubMed ID: 9407401
[TBL] [Abstract][Full Text] [Related]
13. BMP depletion occurs during prolonged acid demineralization of bone: characterization and implications for graft preparation.
Pietrzak WS; Ali SN; Chitturi D; Jacob M; Woodell-May JE
Cell Tissue Bank; 2011 May; 12(2):81-8. PubMed ID: 20039143
[TBL] [Abstract][Full Text] [Related]
14. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide.
Chen B; Lin H; Zhao Y; Wang B; Zhao Y; Liu Y; Liu Z; Dai J
J Biomed Mater Res A; 2007 Feb; 80(2):428-34. PubMed ID: 17013862
[TBL] [Abstract][Full Text] [Related]
15. Alkali-urea extraction of demineralized bone matrix removes noggin, an inhibitor of bone morphogenetic proteins.
Behnam K; Brochmann E; Murray S
Connect Tissue Res; 2004; 45(4-5):257-60. PubMed ID: 15763935
[TBL] [Abstract][Full Text] [Related]
16. Identification of bone morphogenetic proteins 2 and 4 in commercial demineralized freeze-dried bone allograft preparations: pilot study.
Li H; Pujic Z; Xiao Y; Bartold PM
Clin Implant Dent Relat Res; 2000; 2(2):110-7. PubMed ID: 11359264
[TBL] [Abstract][Full Text] [Related]
17. Variability of BMP-2 content in DBM products derived from different long bone.
Zhao YJ; Yin G; Liu B; Deng XQ; Cao HY; Liu Y
Cell Tissue Bank; 2024 Jun; 25(2):697-703. PubMed ID: 38489016
[TBL] [Abstract][Full Text] [Related]
18. The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies.
Zhao Y; Zhang J; Wang X; Chen B; Xiao Z; Shi C; Wei Z; Hou X; Wang Q; Dai J
J Control Release; 2010 Jan; 141(1):30-7. PubMed ID: 19580831
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of osteoinduction/chondroinduction by demineralized bone.
Glowacki J; Zhou S; Mizuno S
J Craniofac Surg; 2009 Mar; 20 Suppl 1():634-8. PubMed ID: 19169155
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo optimization of impaction allografting by demineralization and addition of rh-OP-1.
Tsiridis E; Ali Z; Bhalla A; Heliotis M; Gurav N; Deb S; DiSilvio L
J Orthop Res; 2007 Nov; 25(11):1425-37. PubMed ID: 17557338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
